2/21/2014 6:59:42 AM
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that President and CEO, Christopher Anzalone, Ph.D., will present at the 2014 RBC Capital Markets' Global Healthcare Conference on Wednesday, February 26, 2014 at 3:30 p.m. EST at the New York Palace Hotel.
Help employers find you! Check out all the jobs and post your resume.
comments powered by